Real-World Experience of Hepatitis C Treatment With Glecaprevir-Pibrentasvir During Pregnancy
Clinical Infectious Diseases · 2026
DOI: 10.1093/cid/ciag422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von L Madeline McCrary und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Washington University in St Louis School of Medicine, St Louis, Missouri, USA. Hauptthemen laut MEDLINE: Benzimidazoles, Sulfonamides, Antiviral Agents, Quinoxalines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIDA NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
Guidelines endorse antenatal hepatitis C virus treatment following shared decision making. No clinical trial or real-world data exist for glecaprevir-pibrentasvir (GLE/PIB). We report our experience with prenatal GLE/PIB in 14 patients. Ten patients completed treatment; all achieved virologic response by or at delivery, with no maternal or neonatal safety concerns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.
- Division of Maternal-Fetal Medicine and Ultrasound, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.
- Infectious Diseases Section, John Cochran Veterans Administration Medical Center, St Louis, Missouri, USA.
ORCID-Profile: L Madeline McCrary, Megan R Curtis, Patrick Kojima, Jennifer L Mullersman
Förderung
- NIAID NIH HHS
- NIDA NIH HHS
- NICHD NIH HHS
- NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute on Drug Abuse, NIH
- National Institute of Allergy and Infectious Diseases, NIH
- National Institutes of Health
Zitieren
APA
McCrary, L. M., Curtis, M. R., Kelly, J. C., Elrod-Gallegos, J., Kojima, P., Werner, P., Mullersman, J. L., Habrock-Bach, T., Durkin, M. J., & Marks, L. R. (2026). Real-World Experience of Hepatitis C Treatment With Glecaprevir-Pibrentasvir During Pregnancy. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag422
Vancouver
McCrary LM, Curtis MR, Kelly JC, Elrod-Gallegos J, Kojima P, Werner P, et al. Real-World Experience of Hepatitis C Treatment With Glecaprevir-Pibrentasvir During Pregnancy. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag422
BibTeX
@article{McCrary2026,
author = {McCrary, L Madeline and Curtis, Megan R and Kelly, Jeannie C and Elrod-Gallegos, Jessica and Kojima, Patrick and Werner, Patricia and Mullersman, Jennifer L and Habrock-Bach, Tracey and Durkin, Michael J and Marks, Laura R},
title = {Real-World Experience of Hepatitis C Treatment With Glecaprevir-Pibrentasvir During Pregnancy},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciag422}
}
EUVIMED